321 related articles for article (PubMed ID: 12049568)
1. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
Wax MK; Myers LL; Gabalski EC; Husain S; Gona JM; Nabi H
Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568
[TBL] [Abstract][Full Text] [Related]
2. Chest radiography or chest CT plus head and neck CT versus
Kim Y; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
[TBL] [Abstract][Full Text] [Related]
3. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
Mani N; George MM; Nash L; Anwar B; Homer JJ
Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
[TBL] [Abstract][Full Text] [Related]
4. Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
Gourin CG; Watts TL; Williams HT; Patel VS; Bilodeau PA; Coleman TA
Laryngoscope; 2008 Apr; 118(4):671-5. PubMed ID: 18197136
[TBL] [Abstract][Full Text] [Related]
5. Positron emission tomography in the evaluation of the N0 neck.
Myers LL; Wax MK; Nabi H; Simpson GT; Lamonica D
Laryngoscope; 1998 Feb; 108(2):232-6. PubMed ID: 9473074
[TBL] [Abstract][Full Text] [Related]
6. Role of chest CT scanning in the management of patients presenting with head and neck cancer.
Houghton DJ; Hughes ML; Garvey C; Beasley NJ; Hamilton JW; Gerlinger I; Jones AS
Head Neck; 1998 Oct; 20(7):614-8. PubMed ID: 9744461
[TBL] [Abstract][Full Text] [Related]
7. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
[TBL] [Abstract][Full Text] [Related]
8. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
9. Positron emission tomography in the evaluation of stage III and IV head and neck cancer.
Teknos TN; Rosenthal EL; Lee D; Taylor R; Marn CS
Head Neck; 2001 Dec; 23(12):1056-60. PubMed ID: 11774391
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of intrathoracic lesions detected by 18F-fluorodeoxyglucose positron emission tomography in the management of patients with head and neck cancer.
Roh JL; Ryu CH; Kim JS; Lee JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Sep; 43(8):757-63. PubMed ID: 17112773
[TBL] [Abstract][Full Text] [Related]
11. Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer.
Myers LL; Wax MK
J Otolaryngol; 1998 Dec; 27(6):342-7. PubMed ID: 9857320
[TBL] [Abstract][Full Text] [Related]
12. Value of fluoro-2-deoxy-D-glucose-positron emission tomography for detecting metastatic lesions in head and neck cancer.
Fogh SE; Kubicek GJ; Champ C; Intenzo C; Axelrod R; Keane WM; Machtay MM
Am J Clin Oncol; 2012 Aug; 35(4):311-5. PubMed ID: 22772424
[TBL] [Abstract][Full Text] [Related]
13. FDG PET evaluation of head and neck cancer: value of imaging the thorax.
Keyes JW; Chen MY; Watson NE; Greven KM; McGuirt WF; Williams DW
Head Neck; 2000 Mar; 22(2):105-10. PubMed ID: 10679897
[TBL] [Abstract][Full Text] [Related]
14. Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound.
Fakhry N; Michel J; Colavolpe C; Varoquaux A; Dessi P; Giovanni A
Clin Otolaryngol; 2012 Jun; 37(3):197-206. PubMed ID: 22520870
[TBL] [Abstract][Full Text] [Related]
15. Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.
Strobel K; Haerle SK; Stoeckli SJ; Schrank M; Soyka JD; Veit-Haibach P; Hany TF
Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):919-27. PubMed ID: 19205699
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck.
Fischbein NJ; AAssar OS; Caputo GR; Kaplan MJ; Singer MI; Price DC; Dillon WP; Hawkins RA
AJNR Am J Neuroradiol; 1998 Aug; 19(7):1189-96. PubMed ID: 9726451
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bone and 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in the evaluation of bony metastases in lung cancer.
Gayed I; Vu T; Johnson M; Macapinlac H; Podoloff D
Mol Imaging Biol; 2003; 5(1):26-31. PubMed ID: 14499159
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of F-18 fluorodeoxyglucose positron emission tomography for the evaluation of malignancy in patients presenting with new lung abnormalities: a retrospective review.
Lee J; Aronchick JM; Alavi A
Chest; 2001 Dec; 120(6):1791-7. PubMed ID: 11742903
[TBL] [Abstract][Full Text] [Related]
19. Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.
Stokkel MP; ten Broek FW; Hordijk GJ; Koole R; van Rijk PP
Ann Surg; 2000 Feb; 231(2):229-34. PubMed ID: 10674615
[TBL] [Abstract][Full Text] [Related]
20. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]